NO20032667L - Cykliseringsfremgangsmåtetrinn for fremstilling av kinoloner og naftyridiner - Google Patents

Cykliseringsfremgangsmåtetrinn for fremstilling av kinoloner og naftyridiner

Info

Publication number
NO20032667L
NO20032667L NO20032667A NO20032667A NO20032667L NO 20032667 L NO20032667 L NO 20032667L NO 20032667 A NO20032667 A NO 20032667A NO 20032667 A NO20032667 A NO 20032667A NO 20032667 L NO20032667 L NO 20032667L
Authority
NO
Norway
Prior art keywords
naphthyridines
quinolones
preparation
process steps
cyclization process
Prior art date
Application number
NO20032667A
Other languages
English (en)
Other versions
NO20032667D0 (no
NO325236B1 (no
Inventor
Sreenivasa Reddy Mundla
Jared Lynn Randall
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20032667D0 publication Critical patent/NO20032667D0/no
Publication of NO20032667L publication Critical patent/NO20032667L/no
Publication of NO325236B1 publication Critical patent/NO325236B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
NO20032667A 2000-12-14 2003-06-12 Cykliseringsfremgangsmatetrinn for fremstilling av kinoloner og naftyridiner NO325236B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25563300P 2000-12-14 2000-12-14
PCT/US2001/048536 WO2002048113A1 (en) 2000-12-14 2001-12-07 Cyclization process step in the making of quinolones and naphthyridines

Publications (3)

Publication Number Publication Date
NO20032667D0 NO20032667D0 (no) 2003-06-12
NO20032667L true NO20032667L (no) 2003-08-14
NO325236B1 NO325236B1 (no) 2008-03-03

Family

ID=22969207

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032667A NO325236B1 (no) 2000-12-14 2003-06-12 Cykliseringsfremgangsmatetrinn for fremstilling av kinoloner og naftyridiner

Country Status (19)

Country Link
EP (1) EP1343766B1 (no)
JP (2) JP4417007B2 (no)
KR (1) KR100603163B1 (no)
CN (1) CN1232508C (no)
AT (1) ATE300522T1 (no)
AU (2) AU2002229057B2 (no)
BR (1) BR0116229A (no)
CA (1) CA2427831C (no)
CZ (1) CZ20031379A3 (no)
DE (1) DE60112325T2 (no)
DK (1) DK1343766T3 (no)
ES (1) ES2247190T3 (no)
HU (1) HUP0303991A3 (no)
IL (2) IL155677A0 (no)
MX (1) MXPA03005338A (no)
NO (1) NO325236B1 (no)
NZ (1) NZ525569A (no)
PL (1) PL207394B1 (no)
WO (1) WO2002048113A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
KR100735587B1 (ko) * 2002-08-05 2007-07-04 더 프록터 앤드 갬블 캄파니 퀴놀론계 항생제 중간체의 제조 방법
TR200401663T1 (tr) 2002-11-20 2005-04-21 Japan Tobacco Inc. 4-oksokuinolin bileşiği ve bunun HIV integraz inhibitörü olarak kullanımı.
US7402674B2 (en) 2004-01-31 2008-07-22 Sanofi-Aventis Deutschland Gmbh, 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
CN101437801B (zh) 2006-03-06 2013-02-06 日本烟草产业株式会社 制备4-氧代喹啉化合物的方法
ES2531190T3 (es) 2006-03-06 2015-03-11 Japan Tobacco Inc Método para producir un compuesto de 4-oxoquinolina
KR101565169B1 (ko) * 2006-09-12 2015-11-02 길리애드 사이언시즈, 인코포레이티드 인테그라제 억제제의 제조를 위한 방법 및 중간체
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
WO2010002415A1 (en) 2008-07-01 2010-01-07 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
KR20150040340A (ko) 2012-08-03 2015-04-14 길리애드 사이언시즈, 인코포레이티드 인테그라아제 저해제 제조를 위한 방법 및 중간체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds

Also Published As

Publication number Publication date
CA2427831C (en) 2009-08-18
PL363355A1 (en) 2004-11-15
DK1343766T3 (da) 2005-10-31
KR100603163B1 (ko) 2006-07-24
JP2004515542A (ja) 2004-05-27
DE60112325T2 (de) 2006-05-24
ATE300522T1 (de) 2005-08-15
HUP0303991A2 (hu) 2004-04-28
CN1481365A (zh) 2004-03-10
AU2905702A (en) 2002-06-24
IL155677A0 (en) 2003-11-23
DE60112325D1 (de) 2005-09-01
ES2247190T3 (es) 2006-03-01
CZ20031379A3 (cs) 2003-11-12
MXPA03005338A (es) 2003-10-06
AU2002229057B2 (en) 2005-04-21
EP1343766A1 (en) 2003-09-17
JP2010001315A (ja) 2010-01-07
NO20032667D0 (no) 2003-06-12
BR0116229A (pt) 2003-11-04
WO2002048113A1 (en) 2002-06-20
NZ525569A (en) 2004-09-24
HUP0303991A3 (en) 2012-09-28
JP4417007B2 (ja) 2010-02-17
KR20030063420A (ko) 2003-07-28
CA2427831A1 (en) 2002-06-20
EP1343766B1 (en) 2005-07-27
PL207394B1 (pl) 2010-12-31
CN1232508C (zh) 2005-12-21
IL155677A (en) 2009-02-11
NO325236B1 (no) 2008-03-03

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03009600A (es) Analogos de nociceptina.
TNSN05245A1 (en) A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones
NO20032667D0 (no) Cykliseringsfremgangsmåtetrinn for fremstilling av kinoloner og naftyridiner
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
PT1419163E (pt) Imidazopiridinas triciclicas
MXPA04001647A (es) Proceso para la preparacion de un derivado de 14-hidroxinormorfinona.
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
NO324252B1 (no) Fremgangsmate for fremstilling av en substituert imidazopyridinforbindelse
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen
WO2003044877A3 (en) Light emitting device and compounds for use therein
NO993154L (no) Fremgangsmåte for fremstilling av imidazolderivater
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE518870T1 (de) Verfahren zur herstellung von camptothecin- derivaten
HU0001287D0 (en) New intermediate and process for its production
MXPA05005830A (es) Metodos para preparar derivados de fenilalquino.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees